HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

PCA 4248

structure given in first source; platelet activating factor antagonist
Also Known As:
2-(phenylthio)ethyl-5-methoxycarbonyl-2,4,6-trimethyl-1,4-dihydropyridine-3-carboxylate; 3-(2-(phenylthio)ethyl)-5-methoxycarbonyl-4-methyl-2,6-dimethyl-1,4-dihydropyridine-3-carboxylate; PCA-4248; PTEMC
Networked: 10 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Chu, Yan-Feng: 1 article (04/2014)
2. Zhang, Xian-Zheng: 1 article (04/2014)
3. Wang, Hua-Fen: 1 article (04/2014)
4. Feng, Jun: 1 article (04/2014)
5. Zhuo, Ren-Xi: 1 article (04/2014)
6. Jia, Hui-Zhen: 1 article (04/2014)
7. Bambach, Isabella: 1 article (02/2011)
8. Huettner, Barbara: 1 article (02/2011)
9. Koefeler, Harald: 1 article (02/2011)
10. Mayer, Gerlinde: 1 article (02/2011)

Related Diseases

1. Edema
2. Thrombocytopenia (Thrombopenia)
3. Hypotension (Low Blood Pressure)
4. Anaphylaxis (Anaphylactic Shock)
5. Sepsis (Septicemia)

Related Drugs and Biologics

1. Platelet Activating Factor
2. Antigens
3. WEB 2086 (apafant)
4. Terfenadine (Seldane)
5. 4,5- Dihydro- 1- (3- (trifluoromethyl)phenyl)- 1H- pyrazol- 3- amine
6. Meclizine (Meclozine)
7. Lipoxygenase (Lipoxygenase-1)
8. Indomethacin (Indometacin)
9. Immunoglobulin E (IgE)
10. Drug Carriers

Related Therapies and Procedures

1. Ligation
2. Drug Therapy (Chemotherapy)
3. Oral Administration